Skip to main content
. 2017 May 9;8(37):61011–61024. doi: 10.18632/oncotarget.17723

Figure 7. AAV-Sirt6 delivery protects bleomycin-induced pulmonary fibrosis.

Figure 7

GFPAAV and Sirt6AAV mice were treated with 2 mg/kg bleomycin for 21 days. Sections of pulmonary tissues were harvested at day 21 and subjected to HE (A), Masson’s trichrome staining (B), and IHC staining for FN (C) and CTGF (D) (magnification, 100 ×). n = 6 mice per group.